TP53 and central nervous system cancer: Moreover, in an animal model of mIDH1 glioma in the context of ATRX and TP53 mutations, it has been observed that the presence of this mutation reprograms the tumor cell transcriptome, which affects not only immune cell infiltration but also the bone marrow differentiation of the granulocytic lineage (15).